Skip to Content


Active Substance: telmisartan / amlodipine besilate
Common Name: telmisartan / amlodipine
ATC Code: C09DB04
Marketing Authorisation Holder: Boehringer Ingelheim International GmbH
Active Substance: telmisartan / amlodipine besilate
Status: Withdrawn
Authorisation Date: 2011-11-24
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Cardiovascular system

Therapeutic Indication

Treatment of essential hypertension in adults:

Add on therapy

Onduarp is indicated in adults whose blood pressure is not adequately controlled on amlodipine.

Replacement therapy

Adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of Onduarp containing the same component doses.

The marketing authorisation for Onduarp has been withdrawn at the request of the marketing-authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.